Imbria Pharmaceuticals Announces Publication of IMPROVE-DiCE Phase 2a Data in Circulation, Demonstrating Ninerafaxstat as a Potential First-in-Class Therapy Targeting Cardiac ...

Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart ...
ktiv

Healthbeat 4: First MercyOne Siouxland patient receives Cardiac Contractility Modulation Therapy procedure

SIOUX CITY (KTIV) - Brad Hedlund has been in and out of appointments with cardiologists dealing with heart failure over the last decade. Hedlund explained his symptoms as “I had no energy. I had no ...
WGRZ

New device helps patients with heart failure

BUFFALO, N.Y. — It is considered groundbreaking technology in Buffalo when it comes to heart health. Cardiac Contractility Modulation Therapy (CCM) is a device that can be implanted in patients. There ...
TCTMD

Real-World Survival Comparison of Symptomatic Patients With Heart Failure Treated With Cardiac Contractility Modulation (CCM) vs. Cardiac Resynchronization Therapy (CRT)

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Nasdaq

Orchestra BioMed Receives FDA Breakthrough Device Designation for Atrioventricular Interval Modulation Therapy to Address Uncontrolled Hypertension

Orchestra BioMed has announced that the FDA has granted Breakthrough Device Designation for its atrioventricular interval modulation (AVIM) therapy, aimed at treating over 7.7 million U.S. patients ...
News Medical

Macrophage-targeted therapy could enhance cardiac regeneration and myocardial repair

A new review published in Genes & Diseases highlights macrophage-targeted therapy as a promising frontier in cardiac regeneration and myocardial repair. The findings underscore the critical role of ...
WZZM

Man receives first CCM therapy for heart failure in West Michigan

GRAND RAPIDS, Mich. — It is tough to tell Tracey Bennett to slow down. He loves to hunt and fish, and had cattle on his property. 13 years ago, he had a heart attack. Afterward, he had a pacemaker and ...

Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology

With over 80 issued patents and 39 pending patent applications, Autonomix is building a comprehensive, global IP portfolio in ...

Imbria Pharmaceuticals Announces Publication of IMPROVE-DiCE Phase 2a Data in Circulation, Demonstrating Ninerafaxstat as a Potential First-in-Class Therapy Targeting Cardiac ...

Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart failure with preserved ejection fraction (HFpEF) In ...